If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||
![]() Orthodontics & Craniofacial ResearchVolume 8 Issue 3, Pages 150 - 161 Published Online: 15 Jul 2005 © 2010 John Wiley & Sons A/S
Abstract | References | Full Text: HTML, PDF (Size: 680K) | Related Articles | Citation Tracking Advances in skeletal tissue engineering with hydrogels Copyright 2005 Blackwell Munksgaard KEYWORDS hydrogels • stem cells • tissue engineering ABSTRACTAuthors – Elisseeff J, Puleo C, Yang F, Sharma B. Objectives – Tissue engineering has the potential to make a significant impact on improving tissue repair in the craniofacial system. The general strategy for tissue engineering includes seeding cells on a biomaterial scaffold. The number of scaffold and cell choices for tissue engineering systems is continually increasing and will be reviewed. Design – Multilayered hydrogel systems were developed to coculture different cell types and develop osteochondral tissues for applications including the temporomandibular joint. Experimental variable – Hydrogels are one form of scaffold that can be applied to cartilage and bone repair using fully differentiated cells, adult and embryonic stem cells. Outcome measure – Case studies represent an overview of our laboratory's investigations. Results – Bilayered scaffolds to promote tissue development and the formation of more complex osteochondral tissues were developed and proved to be effective. Conclusion – Tissue engineering provides a venue to investigate tissue development of mutant or diseased cells and potential therapeutics. Dates: Accepted 10 April 2005 |